bpc-157 clinical trials humans bpc 157 human gut trial safety data is being marketed as a “ BPC-157: What the Science Says

It's a strategy that attempts to get the best of both worldsthe full-body benefits of systemic administration with a localized boost

Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress

doi: 10.1080/08916934.2020.1846183 290 XiaXTangXWangS

The tradeoff is that higher doses require substantial volumes, and a full 2.4mg maintenance dose would require nearly 1.44ml, which exceeds the capacity of a standard 1ml insulin syringe

It works by inhibiting the NNMT enzyme, which is associated with fat storage, insulin resistance, and reduced cellular energy

The Role of the Interleukin (IL)-6/IL-6 Receptor axis in Cancer